Skip to content

Companies Investors Funds People Markets

/

Loading company…

Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

© 2026 CapbaseData CC BY-NC 4.0 · Code AGPL-3.0support@capbase.fyi

Converge Bio Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

C

Converge Bio Inc.

Private

Private securities offering disclosed via SEC Form D.

Biotechnology

SEC CIK: 0002131104

Founded: 2024Source: [SEC]
Headquarters: CLAYMONT, DELAWARESource: [SEC]
Headcount: 0Source: [SEC]
Stage: Series B
Sector: Healthcare

$25MSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Overview

Converge Bio Inc. filed a Form D notice of exempt offering with the SEC.

Funding rounds

1 rounds

Private placement (Form D)Sep 2025Source: [SEC]
$25M
—post-money

Investors

No investors recorded yet for Converge Bio Inc..

Add an investor

People

Leadership

Dov GertzExecutive OfficerSince 2026Source: [SEC]

Oded KalevExecutive OfficerSince 2026Source: [SEC]

Showing 2 of 5 — any approved contribution unlocks every profile for 30 days.Sign in to unlock

Acquisitions

Converge Bio Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Diversity investments

No diversity signals recorded yet for Converge Bio Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.